CD8A and neoplasm: As is known, lymphocytes can reduce malignant progression as tumor infiltration via a series of subtypes of lymphocytes, CD3+ T cells, CD8+ T cells, Th1 CD4+ T cell, and p46+ natural killer cells, which has been shown to improve the survival of patients with malignancy [36–39].